BI-RADS(R) 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
CONCLUSION: In this study the malignancy rate of MRI-BI-RADS® 3 lesions corresponded to mammographic BI-RADS® 3 lesions. Initial short-interval MRI should be suggested to identify malignant MRI-BI-RADS® 3 lesions.
PMID: 23969262 [PubMed - as supplied by publisher]
Source: Acta Radiologica - Category: Radiology Authors: Bahrs SD, Baur A, Hattermann V, Hahn M, Vogel U, Claussen CD, Siegmann-Luz KC Tags: Acta Radiol Source Type: research
More News: Breast Carcinoma | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Mammography | MRI Scan | Radiology | Study